Security News cve authentication
SEC News Critical

IBM Aspera Faspex authorization flaw is under active exploitation

CISA reports active exploitation of CVE-2026-123218, a critical authorization flaw in IBM Aspera Faspex 5.0.0 through 5.0.19, fixed in 5.0.19 PL1.

KT Kusal Tharindu

The U.S. Cybersecurity and Infrastructure Security Agency (CISA) reports active exploitation of an authorization flaw in IBM Aspera Faspex 5.0.0 through 5.0.19. The flaw is tracked as CVE-2026-123218, a Common Vulnerabilities and Exposures (CVE) identifier. CISA added the flaw to its Known Exploited Vulnerabilities (KEV) catalog on November 9, 2026.

What is affected

The affected product is IBM Aspera Faspex, and the affected versions are 5.0.0 through 5.0.19. The vulnerability is classified as CWE (Common Weakness Enumeration) 863, incorrect authorization. An authenticated user can craft a specific message to bypass authorization and gain full administrative privileges.

Why it matters

The CVSS (Common Vulnerability Scoring System) base score is 9.8, critical. The fixed release is IBM Aspera Faspex 5.0.19 PL1, which fixes CVE-2026-123218. The KEV entry sets a CISA remediation due date of November 12, 2026.

What to do

For deployments in the affected range, upgrade to IBM Aspera Faspex 5.0.19 PL1. CISA requires applying mitigations in accordance with vendor instructions.

Sources

  1. Security Bulletin: IBM Aspera Faspex has addressed a vulnerability that could allow authorization bypass
  2. NVD: CVE-2026-123218
  3. CISA: Known Exploited Vulnerabilities catalog
3 posts

Discussion

Spotted an error? Send corrections to [email protected] .

Search Oxelan Signal

Type to search the archive.

Search by title, tag, summary or body text.